Neurological infection

Lancet Neurology

Volumn 3, Issue 1, 2004, Pages 13-

  Kennedy, Peter G E ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; ALPHA2A INTERFERON; VIRUS VACCINE;

BRAIN INFECTION; CLINICAL FEATURE; CLINICAL TRIAL; DEATH; DISEASE SEVERITY; DRUG COST; EPIDEMIC; HOSPITAL DISCHARGE; HUMAN; JAPANESE ENCEPHALITIS VIRUS; NEUROLOGIC DISEASE; PHENOTYPE; PRIORITY JOURNAL; SERODIAGNOSIS; SHORT SURVEY; TRAVEL; TREATMENT OUTCOME; VACCINATION; VIRUS ENCEPHALITIS; VIRUS INFECTION; WEST NILE FLAVIVIRUS;

EID: 0347511653     PISSN: 14744422     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1474-4422(03)00613-6     Document Type: Note

References (6)

1. Sejvar J.J., Haddad M.B., Tierney B.C., et al. Neurologic manifestations and outcome of West Nile virus infection. JAMA. 290:2003;511-515.
2. Solomon T., Dung N.M., Willis B., et al. Interferon alfa-2a in Japanese encephalitis: a randomised double-blind placebo-controlled trial. Lancet. 361:2003;821-826.
3. Hevner R., Vilela M., Rostomily R., et al. An unusual cause of trigeminal-distribution pain and tumour. Lancet Neurol. 2:2003;567-571.
4. Anthony I.C., Crawford D.H., Bell J.E. B lymphocytes in the normal brain: contrasts with HIV-associated lymphoid infiltrates and lymphomas. Brain. 126:2003;1058-1067.
5. Kastenbauer S., Pfister H-W. Pneumococcal meningitis in adults. Spectrum of complications and prognostic factors in a series of 87 cases. Brain. 126:2003;1015-1015.
6. Davis L.E., Greenlee J.E. Pneumococcal meningitis: antibiotics essential but insufficient. Brain. 126:2003;1013-1014.